The road to drug development: How to strategically navigate commercialization to achieve long-term success
Thursday, December 6th
Yale Medical School
The Anlyan Center for Medical Research (TAC)
300 Cedar St, New Haven, CT
4:30 p.m. to 6:00 p.m.
Reception to follow
Overview
Join Yale, PAREXEL and Health Advances in an interactive discussion of partnering and commercialization strategies for early stage medtech and biotech entrepreneurs. We invite you to engage on when and why to partner and how to develop product strategies to set the path for clinical and commercial success.
Topics for discussion include:
Best practices for emerging biopharma companies when exploring funding from venture firms or larger pharmaceutical partners
Critical commercial success factors for maximizing company value
Weighing funding vs long-term partnership options
Identifying the right exit strategy based upon internal expertise and corporate objectives
Speakers:
Peyton Howell, Chief Commercial and Strategy Officer, PAREXEL International
Marc Pelletier, Chief Executive Officer & Chief Scientific Officer, Aeromics
Wyatt Gotbetter, Partner, Health Advances
John G. Houston, President and Chief Executive Officer, Arvinas
John Tilton, Chief Commercial Officer, Biohaven Pharmaceuticals
